SCHEMBL8697127

SCHEMBL8697127

COC(=O)/C=C/c1ccc(OC)c(C=O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.64
FDPS P14324 2/20 0.63
KDM4E B2RXH2 5/20 0.58
ALDH1A1 P00352 5/20 0.58
MAPT P10636 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
GAA P10253 2/20 0.58
HTT P42858 2/20 0.58
JAK2 O60674 1/20 0.58
APP P05067 4/20 0.56
TTR P02766 1/20 0.56
GLO1 Q04760 2/20 0.55
NFE2L2 Q16236 2/20 0.55
PTPN1 P18031 1/20 0.54
CA12 O43570 2/20 0.53
CA1 P00915 2/20 0.53
CA2 P00918 2/20 0.53
TYR P14679 2/20 0.53
CA7 P43166 2/20 0.53
CA9 Q16790 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8697176 0.88 EPHX2 (0.56) EPHX2FDPSKDM4EALDH1A1MAPT
SCHEMBL19504285 0.88 EPHX2 (0.68) EPHX2FDPSKDM4EALDH1A1MAPT
SCHEMBL15111041 0.86 KDM4E (0.71) KDM4EALDH1A1SMN1; SMN2GAAGLO1
SCHEMBL15111043 0.86 KDM4E (0.71) KDM4EALDH1A1SMN1; SMN2GAAGLO1
SCHEMBL13070900 0.85 GLO1 (0.55) FDPSKDM4EALDH1A1MAPTSMN1; SMN2
Methyl Cis-3,4-Dimethoxycinnamate SCHEMBL2411956 0.84 FDPS (0.80) EPHX2FDPSKDM4EALDH1A1MAPT
Methyl Cis-3,4-Dimethoxycinnamate SCHEMBL2411955 0.84 FDPS (0.80) EPHX2FDPSKDM4EALDH1A1MAPT
SCHEMBL9397987 0.81 EPHX2 (0.77) EPHX2FDPSKDM4EALDH1A1MAPT
SCHEMBL8320184 0.81 EPHX2 (0.77) EPHX2FDPSKDM4EALDH1A1MAPT
SCHEMBL10951487 0.81 EPHX2 (0.68) EPHX2FDPSKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5756527-A ANTICARCINOGENIC AGENTS ONTOGEN CORPORATION (US) 1998-05-26 US disclosed
EP-0812830-A1 Modulators of multi-drug resistances ONTOGEN CORPORATION (US) 1997-12-17 EP disclosed